Skip to main content
. 2021 Jul 22;17(7):e1009682. doi: 10.1371/journal.ppat.1009682

Fig 2. Flow chart summarizing the most important achievements from the isolation of PF1022A to recent and future human trials.

Fig 2

Milestones with pharmaceutical industry in lead are shown in blue, and milestones achieved with academia in lead are shown in yellow. BK, Big Potassium; DNDi, Drugs for Neglected Diseases initiative; LAT-1, latrophilin-like receptor.